Edward P. Feener, Chief Scientific Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 66,924 shares at $26.81 ($1.8M) on 2021-06-01, disclosed to the SEC on 2021-06-03.
Open-market sale of $1.8M KALV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.81 | 25,786 | $691K | 38.7% |
| 2 | $26.81 | 25,786 | $691K | 38.7% |
| 3 | $27.21 | 14 | $381 | 0.0% |
| 4 | $26.33 | 7,138 | $188K | 10.5% |
| 5 | $26.33 | 7,138 | $188K | 10.5% |
| 6 | $27.05 | 1,062 |
| $29K |
| 1.6% |
| Total | $26.71 avg | 66,924 | $1.8M | 100% |
| Filing → |
| KALV | SELL | 2024-02-16 | $846K | — | Filing → |
| KALV | SELL | 2024-01-12 | $591K | — | Filing → |
| KALV | SELL | 2024-01-10 | $449K | — | Filing → |